- Home
- AXSM vs CVCO Comparison
AXSM vs CVCO Comparison
Compare AXSM & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- CVCO
- Stock Information
- Founded
- AXSM 2012
- CVCO 1965
- Country
- AXSM United States
- CVCO United States
- Employees
- AXSM N/A
- CVCO N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- CVCO Homebuilding
- Sector
- AXSM Health Care
- CVCO Consumer Discretionary
- Exchange
- AXSM Nasdaq
- CVCO Nasdaq
- Market Cap
- AXSM 4.2B
- CVCO 3.8B
- IPO Year
- AXSM 2015
- CVCO N/A
- Fundamental
- Price
- AXSM $137.75
- CVCO $520.73
- Analyst Decision
- AXSM Strong Buy
- CVCO Buy
- Analyst Count
- AXSM 14
- CVCO 2
- Target Price
- AXSM $158.93
- CVCO $487.50
- AVG Volume (30 Days)
- AXSM 1.1M
- CVCO 59.9K
- Earning Date
- AXSM 02-18-2025
- CVCO 01-30-2025
- Dividend Yield
- AXSM N/A
- CVCO N/A
- EPS Growth
- AXSM N/A
- CVCO 2.67
- EPS
- AXSM N/A
- CVCO 20.25
- Revenue
- AXSM $385,693,000.00
- CVCO $1,927,218,000.00
- Revenue This Year
- AXSM $45.18
- CVCO $14.00
- Revenue Next Year
- AXSM $65.22
- CVCO $8.80
- P/E Ratio
- AXSM N/A
- CVCO $26.18
- Revenue Growth
- AXSM 42.53
- CVCO 4.11
- 52 Week Low
- AXSM $64.11
- CVCO $331.08
- 52 Week High
- AXSM $139.13
- CVCO $544.08
- Technical
- Relative Strength Index (RSI)
- AXSM 74.55
- CVCO 57.20
- Support Level
- AXSM $124.04
- CVCO $514.87
- Resistance Level
- AXSM $130.52
- CVCO $536.95
- Average True Range (ATR)
- AXSM 5.78
- CVCO 13.71
- MACD
- AXSM 1.11
- CVCO -0.99
- Stochastic Oscillator
- AXSM 96.07
- CVCO 45.53
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.